Abstract:<p>Prussian blue (PB) is an USA Food and Drug Administration (U.S. FDA)-approved antidote for the treatment of radioactive element poisoning such as thallium, which has been proved to have outstanding biosafety. Controllable morphology, size and structure of PB-based nanomaterials (PB NMs), and their excellent physicochemical properties, make them play an important role in the biomedical fields, such as drug delivery nano-systems, molecular imaging, and cancer treatment. In recent years, PB NMs have made great progress in cancer theranostics. Therefore, it is a great urgent to systematically summarize the recent progress to better serve the broad community of researchers. This review begins with the synthesis methods, regulatory approaches, and modification methods of PB NMs to achieve more uniform size and morphology. Next, according to the different properties of PB NMs, its application in the cancer theranostics has been gradually expanded, mainly including PB NMs for cancer imaging (single-modal and multi-modal imaging) and cancer therapy (monotherapy and combination therapy). For cancer imaging, single-modal imaging (e.g., photoacoustic (PA) imaging, ultrasound (US) imaging, magnetic resonance (MR) imaging), and multi-modal imaging based on PB NMs are systematically summarized, as well as strategies to improve the diagnostic effectiveness. For monotherapy, PB NMs are extensively used in photothermal therapy (PTT), sonodynamic therapy (SDT), and photodynamic therapy (PDT), owing to their excellent photothermal performance and unique physicochemical properties. Combined cancer therapy based on PB NMs to further enhance the cancer-killing efficiency is also systematically summarized. Moreover, the <em>in vivo</em> long-term toxicity of PB NMs is emphasized. Finally, the challenges, key factors, and the future prospects in the clinical transformation of PB NMs as multifunctional theranostic agents are simultaneously discussed. This review will provide reference and guidance for the design and application of PB NMs in the future bioapplications.</p>

Mn(2+)-doped prussian blue nanocubes for bimodal imaging and photothermal therapy with enhanced performance.

Mn2+-doped prussian blue nanocubes for bimodal imaging and photothermal therapy with enhanced performance.

Mn doped Prussian blue nanoparticles for T1/T2 MR imaging, PA imaging and Fenton reaction enhanced mild temperature photothermal therapy of tumor

"One-for-all"-type, Biodegradable Prussian Blue/Manganese Dioxide Hybrid Nanocrystal for Trimodal Imaging-Guided Photothermal Therapy and Oxygen Regulation of Breast Cancer.

PEGylated Prussian Blue Nanocubes As a Theranostic Agent for Simultaneous Cancer Imaging and Photothermal Therapy.

Enabling Prussian Blue with Tunable Localized Surface Plasmon Resonances: Simultaneously Enhanced Dual-Mode Imaging and Tumor Photothermal Therapy

Manganese-enriched prussian blue nanohybrids with smaller electrode potential and lower charge transfer resistance to enhance combination therapy

Perfluoropentane-encapsulated Hollow Mesoporous Prussian Blue Nanocubes for Activated Ultrasound Imaging and Photothermal Therapy of Cancer.

Magnetic Prussian blue nanoparticles for targeted photothermal therapy under magnetic resonance imaging guidance.

Nanosized Prussian blue and its analogs for bioimaging and cancer theranostics

Manganese mineralization-boosted photothermal conversion efficiency of Prussian blue for cancer therapy

Multifunctional Prussian blue-based nanomaterials: Preparation, modification, and theranostic applications

Controllable synthesis of rare earth (Gd3+,Tm3+) doped Prussian blue for multimode imaging guided synergistic treatment

Porous MnFe2O4-decorated PB Nanocomposites: a New Theranostic Agent for Boosted T 1/T 2 MRI-guided Synergistic Photothermal/magnetic Hyperthermia.

Zn2+ Doped Ultrasmall Prussian Blue Nanotheranostic Agent for Breast Cancer Photothermal Therapy under MR Imaging Guidance

Finely Tuned Prussian Blue-Based Nanoparticles and Their Application in Disease Treatment

Zn 2+ Doped Ultrasmall Prussian Blue Nanotheranostic Agent for Breast Cancer Photothermal Therapy under MR Imaging Guidance.

Construction of Bi/phthalocyanine Manganese Nanocomposite for Trimodal Imaging Directed Photodynamic and Photothermal Therapy Mediated by 808 Nm Light

Magnetically-targeted and near infrared fluorescence/magnetic resonance/photoacoustic imaging-guided combinational anti-tumor phototherapy based on polydopamine-capped magnetic Prussian blue nanoparticles

Prussian blue-coated lanthanide-doped core/shell/shell nanocrystals for NIR-II image-guided photothermal therapy

Designed synthesis of prussian blue@Cu-doped zinc phosphate nanocomposites for chemo/chemodynamic/photothermal combined cancer therapy.